- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1534-6277
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Targeted Therapy and Immunotherapy for Melanoma in Japan ; volume:20 ; number:1 ; day:24 ; month:1 ; year:2019 ; pages:1-13 ; date:1.2019
Current treatment options in oncology ; 20, Heft 1 (24.1.2019), 1-13, 1.2019
- Urheber
-
Namikawa, Kenjiro
Yamazaki, Naoya
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11864-019-0607-8
- URN
-
urn:nbn:de:101:1-2019032013252520755971
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Namikawa, Kenjiro
- Yamazaki, Naoya
- SpringerLink (Online service)
Ähnliche Objekte (12)
Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy
Targeted therapy, immunotherapy, and chemotherapy for chordoma
Roles and mechanisms of aberrant alternative splicing in melanoma — implications for targeted therapy and immunotherapy resistance
Revolutionizing cancer care strategies: immunotherapy, gene therapy, and molecular targeted therapy
Stereotactic radiosurgery combined with targeted/ immunotherapy in patients with melanoma brain metastasis
Immunotherapy of malignant melanoma
SABCS 2017: update on chemotherapy, targeted therapy, and immunotherapy
Partial reprogramming - a model for melanoma targeted therapy resistance
Tumor-targeted nanodrug FSGG/siGal-9 for transdermal photothermal immunotherapy of melanoma
Heterogeneity and molecular landscape of melanoma: implications for targeted therapy
Cutaneous Malignant Melanoma and Targeted Therapy Based on the Biomarkers
Melanoma : Biologically Targeted Therapeutics
Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy
Targeted therapy, immunotherapy, and chemotherapy for chordoma
Roles and mechanisms of aberrant alternative splicing in melanoma — implications for targeted therapy and immunotherapy resistance
Revolutionizing cancer care strategies: immunotherapy, gene therapy, and molecular targeted therapy
Stereotactic radiosurgery combined with targeted/ immunotherapy in patients with melanoma brain metastasis
Immunotherapy of malignant melanoma
SABCS 2017: update on chemotherapy, targeted therapy, and immunotherapy
Partial reprogramming - a model for melanoma targeted therapy resistance
Tumor-targeted nanodrug FSGG/siGal-9 for transdermal photothermal immunotherapy of melanoma
Heterogeneity and molecular landscape of melanoma: implications for targeted therapy
Cutaneous Malignant Melanoma and Targeted Therapy Based on the Biomarkers
Melanoma : Biologically Targeted Therapeutics
Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy
Targeted therapy, immunotherapy, and chemotherapy for chordoma
Roles and mechanisms of aberrant alternative splicing in melanoma — implications for targeted therapy and immunotherapy resistance
Revolutionizing cancer care strategies: immunotherapy, gene therapy, and molecular targeted therapy
Stereotactic radiosurgery combined with targeted/ immunotherapy in patients with melanoma brain metastasis
Immunotherapy of malignant melanoma
SABCS 2017: update on chemotherapy, targeted therapy, and immunotherapy
Partial reprogramming - a model for melanoma targeted therapy resistance
Tumor-targeted nanodrug FSGG/siGal-9 for transdermal photothermal immunotherapy of melanoma
Heterogeneity and molecular landscape of melanoma: implications for targeted therapy
Cutaneous Malignant Melanoma and Targeted Therapy Based on the Biomarkers